Recent Updates
Recently added Catalysts
TRLV Positive Sentiment

Trulieve Receives DEA Registrations for State-Licensed Medical Marijuana Operations

Key Takeaway: Trulieve Cannabis Corp. received DEA registrations for its medical marijuana dispensaries. The company applied in April after the federal rescheduling of medical marijuana to Schedule III. This registration allows Trulieve to operate under the new federal framework for state-licensed businesses.

Market Sentiment Analysis

POSITIVE FACTORS

  • Trulieve received DEA registrations for medical marijuana dispensaries.
  • Federal reclassification opens doors for clinical research.
  • Trulieve's CEO praised the DEA's efforts in cannabis reform.

Full Press Release Details

TALLAHASSEE, Fla., Nov. 2, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., today announced that Trulieve has received registrations for medical marijuana dispensaries as part of the initial registrations issued by the U.S. Drug Enforcement Administration (DEA). On Friday, the DEA announced it has begun the initial issuance of federal registrations to qualifying state licensed medical marijuana dispensaries, marking the first phase of the Attorney General's order in April that established a federal framework for qualifying medical marijuana businesses while maintaining federal controls under the Controlled Substances Act. In April, Trulieve applied for DEA registration for its state-licensed operations following the rescheduling of state-licensed medical marijuana to Schedule III under the Controlled Substances Act.
"Today marks another historic milestone for patients, physicians, and Trulieve, made possible by the bold action taken by the Trump Administration on common sense cannabis reform," said Trulieve Chief Executive Officer Kim Rivers. "Federal reclassification of state licensed medical marijuana opens the door for clinical research while creating a level playing field for responsible operators like Trulieve. We appreciate the DEA's work to advance this historic change and its continued engagement with state-licensed medical cannabis operators as the new federal framework is implemented."
About Trulieve Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S., with established medical marijuana operations in Florida, Georgia, Pennsylvania, and West Virginia. Driven by a core mission to expand access to cannabis, Trulieve serves customers with innovative, high-quality branded products and exceptional experiences. With scaled operations in attractive markets and targeted expansion through its hub strategy, Trulieve is poised for accelerated growth. Trulieve is listed on the NYSE under the symbol TRLV. For more information, please visit Trulieve.com.
Facebook: @Trulieve Instagram: @Trulieve X: @Trulieve

Investor and Media Contact Christine Hersey, Chief Corporate Affairs and Strategy Officer +1 (424) 202-0210 Christine.Hersey@Trulieve.com

Frequently Asked Questions

What did Trulieve announce on November 2, 2026?

Trulieve announced it received DEA registrations for its medical marijuana dispensaries.

What is the significance of the DEA registration?

The registration allows for clinical research and supports cannabis reform.

Who is the CEO of Trulieve?

Kim Rivers is the CEO of Trulieve.

What states does Trulieve operate in?

Trulieve has operations in Florida, Georgia, Pennsylvania, and West Virginia.

Last updated: Nov 2, 2026